ACA
ASMB icon

Avoro Capital Advisors’s Assembly Biosciences ASMB Stock Holding History

Avoro Capital Advisors’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-75,000
Closed -$17.7M – 36
2019
Q1 		$17.7M Sell
75,000
-8,333
-10% -$2.11M 0.77% 23
2018
Q4 		$22.6M Sell
83,333
-4,036
-5% -$1.17M 1.35% 16
2018
Q3 		$38.9M Buy
87,369
+7,083
+9% +$3.32M 1.79% 16
2018
Q2 		$37.8M Sell
80,286
-10,875
-12% -$5.75M 1.45% 22
2018
Q1 		$53.8M Buy
91,161
+2,116
+2% +$1.31M 2.57% 15
2017
Q4 		$48.4M Buy
89,045
+13,448
+18% +$6.09M 3.13% 13
2017
Q3 		$31.7M Buy
75,597
+25,000
+49% +$7.66M 2.46% 17
2017
Q2 		$12.5M Sell
50,597
-7,437
-13% -$2.09M 1.58% 18
2017
Q1 		$17.8M Buy
58,034
+35,510
+158% +$8.71M 2.27% 17
2016
Q4 		$3.28M Buy
22,524
+181
+0.8% +$26.9K 0.66% 28
2016
Q3 		$1.93M Buy
22,343
+594
+3% +$45.9K 0.34% 34
2016
Q2 		$1.45M Buy
+21,749
New +$1.43M 0.32% 33

Other funds holding ASMB

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Avoro Capital Advisors's ASMB Position: Q2 2019 in Review

Avoro Capital Advisors sold out of Assembly Biosciences (ASMB) in Q2 2019, closing a stake of 75,000 shares — an estimated $17.7M sold.

Avoro Capital Advisors first reported a position in ASMB in Q2 2016 and held it in 12 quarters. The position peaked at $53.8M in Q1 2018. 106 funds tracked by Wall St. Rank hold ASMB as of Q2 2019.

  • Avoro Capital Advisors reported no remaining Assembly Biosciences position as of Q2 2019 after selling out during the quarter.
  • Avoro Capital Advisors sold 75,000 Assembly Biosciences shares in Q2 2019, an estimated $17.7M.
  • Avoro Capital Advisors first reported a position in Assembly Biosciences in Q2 2016 and held it in 12 quarters.
  • Avoro Capital Advisors's Assembly Biosciences position peaked at $53.8M in Q1 2018.
  • 106 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2019.

Based on Avoro Capital Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.